Christopher S. Lathan, MD, MS, MPH

Faculty Director for Cancer Care Equity, Dana-Farber Cancer Institute
Medical Director, Dana-Farber Cancer Institute at St. Elizabeth’s Medical Center
Associate Medical Director, Dana-Farber Cancer Institute Network
Assistant Professor of Medicine, Harvard Medical School

Dr. Lathan’s primary research interests are centered on the effects of race, class, and access to care in cancer outcomes, including racial disparities in lung cancer treatment, differences in somatic mutations across racial groups, access to precision medicine by race and social class, equitable distribution of new treatment across populations. Dr. Lathan aims to bridge the gap between research efforts in disparities and the realities of patient care by developing interventions to increase access to high level quality care, developed in part through a high level of community engagement. He is the founding Faculty Director of the Cancer Care Equity Program at the Dana-Farber Cancer Institute, a clinical outreach program that aids in the diagnosis and treatment of cancer for patients at Federally Qualified Health Centers and integrates all three arms of clinical cancer care: prevention, diagnosis/treatment, and survivorship. He is also the Associate Director of the Dana-Farber Network, with a focus on clinical trials accessibility. This effort also provides an opportunity to improve clinical trial accrual among vulnerable populations.